LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 53.50 | 21.74 | 1442 | 5425 | 0.2658 | 0.6934 | MN20160310_N01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 53.50 | 21.74 | 1459 | 5425 | 0.2689 | 0.6959 | MN20160310_N01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 55.48 | 21.74 | 1025 | 5768 | 0.1777 | 0.6138 | MN20160310_N01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 55.48 | 21.74 | 1066 | 5768 | 0.1848 | 0.6216 | MN20160310_N01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 55.48 | 21.74 | 1455 | 5768 | 0.2522 | 0.6855 | MN20160310_N01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 55.48 | 21.74 | 1474 | 5768 | 0.2555 | 0.6882 | MN20160310_N01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 57.45 | 21.74 | 1031 | 6023 | 0.1712 | 0.6090 | MN20160310_N01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 57.45 | 21.74 | 1077 | 6023 | 0.1788 | 0.6177 | MN20160310_N01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 57.45 | 21.74 | 1477 | 6023 | 0.2452 | 0.6819 | MN20160310_N01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 57.45 | 21.74 | 1494 | 6023 | 0.2480 | 0.6843 | MN20160310_N01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 59.42 | 21.74 | 1041 | 6125 | 0.1700 | 0.6086 | MN20160310_N01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 59.42 | 21.74 | 1088 | 6125 | 0.1776 | 0.6174 | MN20160310_N01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 59.42 | 21.74 | 1457 | 6125 | 0.2379 | 0.6765 | MN20160310_N01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 59.42 | 21.74 | 1477 | 6125 | 0.2411 | 0.6793 | MN20160310_N01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 62.39 | 21.74 | 1046 | 6112 | 0.1711 | 0.6099 | MN20160310_N01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 62.39 | 21.74 | 1095 | 6112 | 0.1791 | 0.6189 | MN20160310_N01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 62.39 | 21.74 | 1446 | 6112 | 0.2366 | 0.6752 | MN20160310_N01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 62.39 | 21.74 | 1505 | 6112 | 0.2462 | 0.6835 | MN20160310_N01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 64.36 | 21.74 | 1043 | 6191 | 0.1685 | 0.6076 | MN20160310_N01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 64.36 | 21.74 | 1088 | 6191 | 0.1757 | 0.6159 | MN20160310_N01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 64.36 | 21.74 | 1469 | 6191 | 0.2373 | 0.6765 | MN20160310_N01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 64.36 | 21.74 | 1499 | 6191 | 0.2421 | 0.6807 | MN20160310_N01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 66.33 | 21.74 | 1058 | 6235 | 0.1697 | 0.6094 | MN20160310_N01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 66.33 | 21.74 | 1094 | 6235 | 0.1755 | 0.6160 | MN20160310_N01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 66.33 | 21.74 | 1531 | 6235 | 0.2455 | 0.6839 | MN20160310_N01 | I08 |